IDPH Reports 15 Illinois Counties at an Elevated Community Level for COVID-19
ILLINOIS, February 10 - Department of Public Health Launches STATeam to Provide Support, Treatment & Access to Protect Most Vulnerable Illinoisans in Case of Outbreaks
The STATeam is designed to strengthen IDPH's county health department partners in their efforts to support long term care facilities. The support will include testing, vaccinations, contact tracing and treatments.
IDPH has recorded a total of 4,040,139 cases and 36,229 deaths, in 102 counties in Illinois since the beginning of the pandemic. The department is reporting 10,234 new confirmed and probable cases of COVID-19 in Illinois in the week ending February 5, and 62 deaths.
"We are seeing a slight increase in COVID-19 community levels this week," Director Vohra said. "However, as COVID-19 community levels are relatively low and the State of Illinois plans for the end of the statewide disaster declaration in May, IDPH remains dedicated to staying vigilant and protecting the most vulnerable Illinoisians. This is why we are excited to announce the launch of the new STATeam. This innovative new program will provide additional layers of support for our local health departments and long term care facilities, protecting our most at-risk residents and keeping them safe from COVID-19 and other respiratory illnesses."
IDPH is helping Illinoisans stay prepared for any future surge of COVID-19 cases by offering 1 million free COVID-19 rapid antigen tests to Illinois residents in all zip codes outside the City of Chicago through a partnership with the Rockefeller Foundation's public charity, RF Catalytic Capital and its Project ACT (Access COVID Tests) program.
The CDC authorized two new bivalent booster vaccines on September 1 that include an mRNA component of the original strain to provide an immune response that is broadly protective against COVID-19 and an added mRNA component in common between the omicron variant BA.4 and BA.5 lineages to provide better protection against COVID-19 caused by the omicron variant.
Initially, the Moderna COVID-19 Vaccine, Bivalent, was authorized for use as a single booster dose in individuals 18 years of age and older and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent, was authorized for use as a single booster dose in individuals 12 years of age and older. On October 12, the CDC authorized the updated COVID-19 vaccines from Pfizer-BioNTech for children ages 5 through 11 years, and from Moderna for children and adolescents ages 6 through 17 years.
On December 9, the CDC expanded its authorization for bivalent boosters to include children aged 6 months to 5 years. Children ages 6 months through 5 years who previously completed a Moderna primary series can now receive a Moderna bivalent booster 2 months after their final primary series dose. Children ages 6 months through 4 years who are completing a Pfizer primary series will receive a Pfizer bivalent vaccine as their third primary dose.
As of last night, 834 individuals in Illinois were reported to be in the hospital with COVID-19. Of those, 100 patients were in the ICU and 34 patients with COVID-19 were on ventilators. The preliminary seven-day statewide case rate is 80 COVID-19 cases per 100,000 Illinoisans.
In counties at the Medium Community Level, persons who are elderly or immunocompromised (at risk of severe outcomes) are advised to wear a mask in indoor public places. They should also get up to date on COVID-19 vaccines or get their bivalent booster, if eligible.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.